| Stem definition | Drug id | CAS RN |
|---|---|---|
| ergot alkaloid derivatives | 4420 | 25447-66-9 |
None
None
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA |
None
None
None
None
| Source | Code | Description |
|---|---|---|
| ATC | N04BC03 | NERVOUS SYSTEM ANTI-PARKINSON DRUGS DOPAMINERGIC AGENTS Dopamine agonists |
| MeSH PA | D002317 | Cardiovascular Agents |
| MeSH PA | D015259 | Dopamine Agents |
| MeSH PA | D018491 | Dopamine Agonists |
| MeSH PA | D018377 | Neurotransmitter Agents |
| MeSH PA | D014665 | Vasodilator Agents |
None
None
None
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 12.57 | acidic |
| pKa2 | 13.18 | acidic |
| pKa3 | 13.67 | acidic |
| pKa4 | 7.56 | Basic |
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| 5-hydroxytryptamine receptor 2B | GPCR | AGONIST | Ki | 7.48 | IUPHAR | ||||
| 5-hydroxytryptamine receptor 7 | GPCR | ANTAGONIST | Ki | 6.50 | IUPHAR | ||||
| 5-hydroxytryptamine receptor 7 | GPCR | ANTAGONIST | Ki | 7 | IUPHAR |
| ID | Source |
|---|---|
| D07835 | KEGG_DRUG |
| 14271-05-7 | SECONDARY_CAS_RN |
| 4017832 | VANDF |
| 4020124 | VANDF |
| C0012290 | UMLSCUI |
| CHEMBL1743263 | ChEMBL_ID |
| CHEMBL3707289 | ChEMBL_ID |
| DB13385 | DRUGBANK_ID |
| 282 | IUPHAR_LIGAND_ID |
| 67V3FSL2GL | UNII |
| 114948 | PUBCHEM_CID |
| 1426902 | RXNORM |
| 005801 | NDDF |
| 005802 | NDDF |
| 24650007 | SNOMEDCT_US |
| 412173004 | SNOMEDCT_US |
| 426582003 | SNOMEDCT_US |
| 708572008 | SNOMEDCT_US |
| D025443 | MESH_DESCRIPTOR_UI |
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| Ergoloid Mesylates | HUMAN PRESCRIPTION DRUG LABEL | 4 | 53489-281 | TABLET | 0.22 mg | ORAL | ANDA | 11 sections |
| Ergoloid Mesylates | HUMAN PRESCRIPTION DRUG LABEL | 4 | 68151-2780 | TABLET | 0.22 mg | ORAL | ANDA | 10 sections |